Nava Benefits, a modern healthcare benefits brokerage leveraging technology and benefits innovation, welcomes benefits strategy leader Rick Livesay as Partner. Rick's appointment strengthens Nava's presence in Northern California as well as doubles down on Nava's commitment to bring benefits innovation to employers of any size. Rick will leverage his expansive healthcare experience to continue his track record of delivering for his clients, no matter what.
Rick Livesay joins Nava Benefits as Partner.
Rick joins Nava with more than two decades of healthcare and benefits-centric experience spanning pharma, healthcare delivery systems, managed health care, plan design, and consulting. Most recently, he served as a Business Consultant at Sequoia Consulting Group where he provided benefits expertise to employer groups of all sizes, with a focus on high-growth technology companies.
Rick Livesay states: "I've spent my entire career working to fix healthcare from the business side. Traditional brokerage has been stuck overpromising in finalist meetings while ultimately underdelivering on client outcomes. I was drawn to Nava's product vision and employer-aligned consulting approach, which work to eliminate the noise of everyday, basic inquiries that take up an overwhelming amount of HR's time. Nava delivers a benefits experience that doesn't just benefit the employee; it's amplified throughout the whole organization. Combined with Nava's active Benefits Advisory Board, I can finally empower my clients with the strategy, insights, and benefits innovation they didn't have access to before."
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
2 Commerce Drive
Cranbury, NJ 08512